Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias
Clinical trial NCT01149915 · COMPLETED
Trial details
- NCT number
- NCT01149915
- Sponsor
- Threshold Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2013-08-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.